… , malnutrition-related risk was a prognostic indicator of antifibrotic therapy discontinuation
and mortality, independent of age, sex, forced vital capacity, or gender–age–physiology index. …

Background: There are only a few reports on the nutritional status and mortality of patients
with idiopathic pulmonary fibrosis (IPF). As such, this study aims to investigate the relationship …

… malnutrition-related risk determined by the Geriatric Nutritional Risk Index. p-… antifibrotic
therapy might have had an effect on the small number of patients treated with antifibrotic therapy …

… All cases: Within the scope of our national health system, diagnosis and antifibrotic treatment
decisions in IPF patients require detailed evaluation according to the current guidelines. In …

… When patients have progressive lung function loss and worsening quality of life despite a
disease-centered approach with antifibrotic therapies and other interventions, management …

… of the three nutritional risk assessment tools in predicting osteoporosis in the elderly with
T2DM. Therefore, this study aimed to investigate the correlation between the three nutritional …

… nutritional risk associated with brain abscess in the older. This study aimed to evaluate the
prevalence of nutritional risk … of the Geriatric Nutritional Risk Index (GNRI) in elderly brain …

… nutritional assessments at baseline and 6 months were included in this analysis. The antifibrotic
therapy … because of adverse events, and no antifibrotic therapy was given in 5 cases (7.1…

… , the relation between nutrition and anti-fibrotic therapies has not been carefully … nutritional
status in COPD over the last few years has led to the establishment of different nutritional risk …

… DLCO and fatigue score. Adverse symptoms commonly reported with antifibrotic therapy, such
… frailty; however, there was no difference in antifibrotic use among frailty groups. While the …